SARS-CoV-2所致COVID-19肺炎患者死亡预测因素:一项前瞻性队列研究
该前瞻性队列研究纳入武汉肺科医院住院的COVID-19肺炎患者,通过单因素和多因素logistic回归分析死亡相关因素。校正后的分析显示,年龄≥65岁、既往心脑血管疾病、CD3+CD8+ T细胞≤75 cells·μL−1及心肌肌钙蛋白I≥0.05 ng·mL−1与死亡风险增加相关,后两者在匹配病例对照研究中仍为高死亡预测因素。
要点
- 年龄≥65岁、既往心脑血管疾病、CD3+CD8+ T细胞≤75 cells·μL−1及心肌肌钙蛋白I≥0.05 ng·mL−1为死亡风险因素。
- CD3+CD8+ T细胞≤75 cells·μL−1和心肌肌钙蛋白I≥0.05 ng·mL−1是死亡的重要预测因素。
- 上述因素可用于识别COVID-19肺炎高死亡风险患者。
核心结论
- 年龄≥65岁、既往心脑血管疾病、CD3+CD8+ T细胞≤75 cells·μL−1和心肌肌钙蛋白I≥0.05 ng·mL−1是COVID-19肺炎患者死亡的预测因素。
研究设计与样本
- 采用单因素和多因素logistic回归分析,并进行性别、年龄和合并症匹配的病例对照研究。
主要发现
- 多因素分析显示,年龄≥65岁(OR 3.765,95% CI 1.201–11.803;p=0.023)与死亡风险增加相关。
- 既往心脑血管疾病(OR 2.464,95% CI 1.279–4.747;p=0.007)与死亡风险增加相关。
- CD3+CD8+ T细胞≤75 cells·μL−1(OR 3.982,95% CI 1.761–9.004;p<0.001)与死亡风险增加相关。
- 心肌肌钙蛋白I≥0.05 ng·mL−1(OR 4.077,95% CI 1.778–9.349;p<0.001)与死亡风险增加相关。
- 在性别、年龄和合并症匹配的病例对照研究中,CD3+CD8+ T细胞≤75 cells·μL−1和心肌肌钙蛋白I≥0.05 ng·mL−1仍为高死亡预测因素。
关键数值与推荐
- 年龄≥65岁:OR 3.765,95% CI 1.201–11.803,p=0.023。
- 既往心脑血管疾病:OR 2.464,95% CI 1.279–4.747,p=0.007。
- CD3+CD8+ T细胞≤75 cells·μL−1:OR 3.982,95% CI 1.761–9.004,p<0.001。
- 心肌肌钙蛋白I≥0.05 ng·mL−1:OR 4.077,95% CI 1.778–9.349,p<0.001。
临床怎么用
- 对COVID-19肺炎患者应评估年龄、心脑血管病史、CD3+CD8+ T细胞计数和心肌肌钙蛋白I水平以识别高死亡风险者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The aim of this study was to identify factors associated with the death of patients with COVID-19 pneumonia caused by the novel coronavirus SARS-CoV-2.All clinical and laboratory parameters were collected prospectively from a cohort of patients with COVID-19 pneumonia who were hospitalised to Wuhan Pulmonary Hospital (Wuhan City, Hubei Province, China) between 25 December 2019 and 7 February 2020. Univariate and multivariate logistic regression analysis revealed that age ≥65 years (OR 3.765, 95% CI 1.146–17.394; p=0.023), pre-existing concurrent cardiovascular or cerebrovascular diseases (OR 2.464, 95% CI 0.755–8.044; p=0.007), CD3+CD8+ T-cells ≤75 cells·μL−1 (OR 3.982, 95% CI 1.132–14.006; p<0.001) and cardiac troponin I ≥0.05 ng·mL−1 (OR 4.077, 95% CI 1.166–14.253; p<0.001) were associated with an increase in risk of mortality from COVID-19 pneumonia.” has been corrected to: “Univariate and multivariate logistic regression analysis revealed that age ≥65 years (OR 3.765, 95% CI 1.201−11.803; p=0.023), pre-existing concurrent cardiovascular or cerebrovascular diseases (OR 2.464, 95% CI 1.279−4.747; p=0.007), CD3+CD8+ T-cells ≤75 cells·μL−1 (OR 3.982, 95% CI 1.761–9.004; p<0.001) and cardiac troponin I ≥0.05 ng·mL−1 (OR 4.077, 95% CI 1.778–9.349; p<0.001) were associated with an increase in risk of mortality from COVID-19 pneumonia. In a sex-, age- and comorbid illness-matched case-control study, CD3+CD8+ T-cells ≤75 cells·μL-1 and cardiac troponin I ≥0.05 ng·mL-1 remained as predictors for high mortality from COVID-19 pneumonia.We identified four risk factors: age ≥65 years, pre-existing concurrent cardiovascular or cerebrovascular diseases, CD3+CD8+ T-cells ≤75 cells·μL-1 and cardiac troponin I ≥0.05 ng·mL-1 The latter two factors, especially, were predictors for mortality of COVID-19 pneumonia patients.
引用
- Du RH, Liang LR, Yang CQ, et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J. 2020. PMID: 32269088. doi:10.1183/13993003.00524-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。